As broader approval for GLP-1 weight loss drugs spurs higher demand, it’s also causing employer drug spending to spike.
Related Posts
Ukraine reportedly agrees a critical rare minerals deal with the U.S.
Ukraine and the United States reached an agreement over access to Kyiv’s deposits of rare earth minerals, according to media reports.
US launches new probe into legacy Chinese chips as tech pressure on Beijing escalates
The Biden administration launched a new probe into legacy Chinese semiconductors that may go into everything from cars to household goods and defense systems.
Deutsche Bank says buy GE Vernova, sees 30% potential upside
Shares of GE Vernova could rise due to growth potential in its gas power, wind and electrification businesses, according to Deutsche Bank.